7,446 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Bought by Castlekeep Investment Advisors LLC

Castlekeep Investment Advisors LLC purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 7,446 shares of the medical device company's stock, valued at approximately $685,000.

A number of other hedge funds also recently made changes to their positions in the stock. T. Rowe Price Investment Management Inc. lifted its position in Cooper Companies by 2.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock valued at $705,928,000 after purchasing an additional 155,233 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Cooper Companies by 1.5% in the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock worth $460,066,000 after purchasing an additional 74,501 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Cooper Companies by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after purchasing an additional 109,907 shares during the period. Victory Capital Management Inc. grew its holdings in Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after buying an additional 574,899 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of Cooper Companies by 517.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after purchasing an additional 2,957,421 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded down $0.65 during midday trading on Friday, hitting $82.27. 1,265,544 shares of the company traded hands, compared to its average volume of 1,447,855. The firm's fifty day moving average price is $80.54 and its 200-day moving average price is $90.93. The stock has a market cap of $16.45 billion, a price-to-earnings ratio of 42.19, a PEG ratio of 2.25 and a beta of 1.08. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

COO has been the topic of a number of recent analyst reports. Robert W. Baird reduced their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research report on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Piper Sandler reissued an "overweight" rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.